Cargando…
Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
BACKGROUND: Bleomycin-induced lung injury, a major complication of chemotherapy for germ cell tumors, occasionally fails to respond to the standard treatment with corticosteroids and develops into severe respiratory insufficiency. Little is known about salvage treatment for refractory cases. CASE PR...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547483/ https://www.ncbi.nlm.nih.gov/pubmed/28784103 http://dx.doi.org/10.1186/s12885-017-3521-0 |
_version_ | 1783255700023017472 |
---|---|
author | Sakamoto, Koji Ito, Satoru Hashimoto, Naozumi Hasegawa, Yoshinori |
author_facet | Sakamoto, Koji Ito, Satoru Hashimoto, Naozumi Hasegawa, Yoshinori |
author_sort | Sakamoto, Koji |
collection | PubMed |
description | BACKGROUND: Bleomycin-induced lung injury, a major complication of chemotherapy for germ cell tumors, occasionally fails to respond to the standard treatment with corticosteroids and develops into severe respiratory insufficiency. Little is known about salvage treatment for refractory cases. CASE PRESENTATION: A 63-year-old man who had been diagnosed with stage I seminoma and undergone a high orchiectomy 1 year previously developed swelling of his left iliac lymph node and was diagnosed with a recurrence of the seminoma. He was administered a standard chemotherapy regimen of cisplatin, etoposide, and bleomycin. At the end of second cycle, he developed a dry cough and fever that was accompanied by newly-identified bilateral infiltrates on chest X-ray. Despite initiation of oral prednisolone, his exertional dyspnea and decline in pulmonary functions continued to be aggravated. High-dose pulse treatment with methylprednisolone was introduced and improved his symptoms and radiologic findings. However, the maintenance dose of oral prednisolone allowed reactivation of the disease with evidence of newly-developed bilateral lung opacities on high-resolution CT scans. Considering his glucose intolerance and cataracts as complications of corticosteroid treatment, administration of pirfenidone was initiated with the patient’s consent. Pirfenidone at 1800 mg/day was well tolerated, and resolved his symptoms and abnormal opacities on a chest CT scan. Subsequently, the dose of prednisolone was gradually tapered without worsening of the disease. At the most recent follow-up, he was still in complete remission of seminoma with a successfully tapered combination dose of prednisolone and pirfenidone. CONCLUSIONS: Pirfenidone, a novel oral agent with anti-inflammatory and -fibrotic properties, should be considered as a salvage drug for refractory cases of bleomycin-induced lung injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3521-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5547483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55474832017-08-09 Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma Sakamoto, Koji Ito, Satoru Hashimoto, Naozumi Hasegawa, Yoshinori BMC Cancer Case Report BACKGROUND: Bleomycin-induced lung injury, a major complication of chemotherapy for germ cell tumors, occasionally fails to respond to the standard treatment with corticosteroids and develops into severe respiratory insufficiency. Little is known about salvage treatment for refractory cases. CASE PRESENTATION: A 63-year-old man who had been diagnosed with stage I seminoma and undergone a high orchiectomy 1 year previously developed swelling of his left iliac lymph node and was diagnosed with a recurrence of the seminoma. He was administered a standard chemotherapy regimen of cisplatin, etoposide, and bleomycin. At the end of second cycle, he developed a dry cough and fever that was accompanied by newly-identified bilateral infiltrates on chest X-ray. Despite initiation of oral prednisolone, his exertional dyspnea and decline in pulmonary functions continued to be aggravated. High-dose pulse treatment with methylprednisolone was introduced and improved his symptoms and radiologic findings. However, the maintenance dose of oral prednisolone allowed reactivation of the disease with evidence of newly-developed bilateral lung opacities on high-resolution CT scans. Considering his glucose intolerance and cataracts as complications of corticosteroid treatment, administration of pirfenidone was initiated with the patient’s consent. Pirfenidone at 1800 mg/day was well tolerated, and resolved his symptoms and abnormal opacities on a chest CT scan. Subsequently, the dose of prednisolone was gradually tapered without worsening of the disease. At the most recent follow-up, he was still in complete remission of seminoma with a successfully tapered combination dose of prednisolone and pirfenidone. CONCLUSIONS: Pirfenidone, a novel oral agent with anti-inflammatory and -fibrotic properties, should be considered as a salvage drug for refractory cases of bleomycin-induced lung injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3521-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-07 /pmc/articles/PMC5547483/ /pubmed/28784103 http://dx.doi.org/10.1186/s12885-017-3521-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Sakamoto, Koji Ito, Satoru Hashimoto, Naozumi Hasegawa, Yoshinori Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma |
title | Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma |
title_full | Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma |
title_fullStr | Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma |
title_full_unstemmed | Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma |
title_short | Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma |
title_sort | pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547483/ https://www.ncbi.nlm.nih.gov/pubmed/28784103 http://dx.doi.org/10.1186/s12885-017-3521-0 |
work_keys_str_mv | AT sakamotokoji pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma AT itosatoru pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma AT hashimotonaozumi pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma AT hasegawayoshinori pirfenidoneassalvagetreatmentforrefractorybleomycininducedlunginjuryacasereportofseminoma |